Hanwha Life (088350)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 4,025.00 |
|---|---|
| 52-week range | 2,930.00 – 7,560.00 |
| Return, 1 month / 3 months | −28.6% / −12.4% |
| Return, 1 year / 3 years | +29.8% / +48.6% |
| Trend | Below its 200-day average |
| RSI (14) | 22 |
| Volatility (1 year) | 68.0% |
| Worst drawdown (1 year) | -39.0% |
| Average daily value traded | 21,646.41M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hanwha Life is a life insurance company based in Korea and part of the Hanwha business group. It provides protection and savings insurance policies to individual customers, along with related financial products, and it serves customers in its home market as well as in several overseas markets in Southeast Asia. The company collects premiums from policyholders and manages investments to meet its obligations to them.
On this site Hanwha Life appears as a stock on the Korea Stock Exchange (Korea), code 088350, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hanwha Life (088350) trades on the Korea Stock Exchange in Korea. It last closed at KRW 4,025.00 on 23 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 281 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.8% and over the last three months it fell 12.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -15.0% | ||
| From 52-week high | -39.0% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -12.4% | ||
| 6-month return | -17.0% | ||
| 12-month return, skipping the last month | 81.9% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 68.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.0% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 21,646.41M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −15.2% |
|---|---|
| 1 month | −28.6% |
| 3 months | −12.4% |
| 6 months | −17.0% |
| 1 year | +29.8% |
| 3 years | +48.6% |
| 5 years | +20.8% |
Signals
| 50-day / 200-day average | 5,384.30 / 4,736.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 249.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Mar 2024 | KRW 150.0000 |
| 29 Dec 2021 | KRW 30.0000 |
| 29 Dec 2020 | KRW 30.0000 |
| 27 Dec 2019 | KRW 30.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.